Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

TTK Healthcare

₹1472 7.1 | 0.5%

Market Cap ₹2080 Cr.

Stock P/E 36.8

P/B 2.1

Current Price ₹1472

Book Value ₹ 694.1

Face Value 10

52W High ₹1725.9

Dividend Yield 0.68%

52W Low ₹ 1117.1

TTK Healthcare Research see more...

Overview Inc. Year: 1958Industry: Pharmaceuticals & Drugs

TTK Healthcare Ltd is engaged in pharmaceuticals, customer products, medical devices and foods agencies. It's segments include Medical Devices, Consumer Products, Pharmaceuticals, Foods and Others. Its Pharmaceuticals phase includes merchandise for both human and veterinary use. It additionally includes over the counter brands, such as Woodward's Gripewater allotted with the aid of the Consumer Products division. The Woodward's Gripe Water brand offers products inside the baby care category. The Medical Devices segment includes Artificial Heart Valves and Orthopaedic Implants. Its Consumer Products phase includes marketing and distribution of EVA variety of Cosmetics, Good Home Range of Scrubbers and Air Fresheners (Own Brands), and additionally trading of branded condoms. The Eva variety of personal care merchandise consists of talc, deodorant and skincare. The Foods segment consists of production and advertising of food merchandise. Its Others segment includes publishing and printing of atlases and maps.

Read More..

TTK Healthcare Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

TTK Healthcare Quarterly Results

#(Fig in Cr.) Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Jun 2023 Sep 2023 Dec 2023
Net Sales 131 150 159 159 193 170 183 202 186 184
Other Income 4 3 4 5 10 11 12 15 16 16
Total Income 135 154 163 164 202 181 194 217 202 200
Total Expenditure 125 148 150 154 189 166 174 192 176 179
Operating Profit 10 6 13 10 14 15 20 25 26 21
Interest 0 0 1 1 3 1 1 1 1 0
Depreciation 3 3 3 3 3 3 3 3 3 3
Exceptional Income / Expenses 0 2 0 0 0 0 0 0 0 0
Profit Before Tax 6 5 8 6 8 11 16 21 22 18
Provision for Tax 2 1 2 2 3 3 4 5 6 5
Profit After Tax 4 4 6 4 4 8 12 16 16 13
Adjustments 2 9 6 6 597 2 0 -0 -0 -0
Profit After Adjustments 6 13 12 11 601 10 12 16 16 13
Adjusted Earnings Per Share 3.1 2.7 4.4 3 3.1 5.6 8.5 11.1 11.3 9.1

TTK Healthcare Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 382 416 483 519 528 578 628 646 476 599 725 755
Other Income 7 6 7 6 6 8 8 9 10 16 48 59
Total Income 389 422 489 524 534 585 636 655 486 616 773 813
Total Expenditure 362 396 453 478 489 535 578 617 457 577 694 721
Operating Profit 27 26 36 46 44 50 57 37 29 38 80 92
Interest 3 3 4 3 3 5 3 3 2 3 5 3
Depreciation 3 3 6 7 12 15 15 14 13 13 13 12
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 8 2 0 0
Profit Before Tax 22 20 26 36 29 30 39 19 23 25 62 77
Provision for Tax 7 7 10 13 10 12 15 7 -14 6 17 20
Profit After Tax 14 12 16 23 19 18 24 12 37 19 45 57
Adjustments 0 0 0 0 0 0 0 0 10 23 595 0
Profit After Adjustments 14 12 16 23 19 18 24 12 46 42 640 57
Adjusted Earnings Per Share 18.3 16 20.8 29.2 24.1 12.9 17.2 8.7 26 13.1 31.6 40

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 21% 4% 5% 7%
Operating Profit CAGR 111% 29% 10% 11%
PAT CAGR 137% 55% 20% 12%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 20% 35% 19% 11%
ROE Average 7% 9% 8% 12%
ROCE Average 10% 9% 10% 15%

TTK Healthcare Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 98 107 118 136 157 233 251 249 295 330 953
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 1 16 16 1 1 1 0 0 0 0 0
Other Non-Current Liabilities 11 11 12 15 7 2 2 7 4 1 2
Total Current Liabilities 100 106 129 150 120 168 157 172 189 199 211
Total Liabilities 209 240 275 303 285 403 411 427 488 551 1166
Fixed Assets 43 54 52 106 99 110 98 89 85 80 71
Other Non-Current Assets 12 23 57 13 19 38 42 40 27 22 28
Total Current Assets 154 163 166 184 167 256 272 298 375 425 1066
Total Assets 209 240 275 303 285 403 411 427 488 551 1166

TTK Healthcare Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 62 83 84 77 19 19 15 11 8 10 15
Cash Flow from Operating Activities 24 13 39 37 18 25 17 20 96 45 -26
Cash Flow from Investing Activities -1 -15 -49 -27 5 -23 10 -13 -77 -30 33
Cash Flow from Financing Activities -2 2 3 -11 -23 -7 -31 -10 -17 -10 -12
Net Cash Inflow / Outflow 22 0 -7 -0 0 -4 -4 -4 2 5 -6
Closing Cash & Cash Equivalent 83 84 77 77 19 15 11 8 10 15 9

TTK Healthcare Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 18.29 15.95 20.8 29.19 24.13 12.86 17.25 8.72 26.03 13.1 31.61
CEPS(Rs) 21.79 20.04 28.71 38.47 39.47 23.64 27.63 18.89 35.24 22.01 40.67
DPS(Rs) 4 4 4.5 5 5 5 5 3 6 10 10
Book NAV/Share(Rs) 120.6 131.87 146.54 169.71 197.09 161.75 174.81 173.09 205.4 230.16 671.59
Core EBITDA Margin(%) 5.27 4.73 6.12 7.8 7.29 7.37 7.89 4.38 4.06 3.64 4.32
EBIT Margin(%) 6.32 5.44 6.2 7.49 6.12 6.04 6.79 3.51 5.11 4.69 9.22
Pre Tax Margin(%) 5.66 4.72 5.45 6.84 5.53 5.22 6.25 3.01 4.75 4.14 8.5
PAT Margin (%) 3.72 2.98 3.34 4.37 3.55 3.15 3.88 1.91 7.73 3.09 6.16
Cash Profit Margin (%) 4.43 3.74 4.61 5.75 5.81 5.78 6.22 4.13 10.46 5.19 7.93
ROA(%) 7.07 5.51 6.27 7.85 6.38 5.28 5.99 2.94 8.04 3.56 5.2
ROE(%) 16.07 12.64 14.94 18.46 13.16 9.52 10.25 5.01 13.76 6.02 7.01
ROCE(%) 22.23 18.12 20.71 23.85 18.63 15.42 15.46 8.28 8.38 8.59 10.13
Receivable days 34.59 32.18 31.24 32 27.96 28.31 39.41 44.37 52.35 34.52 36.67
Inventory Days 28.54 26.76 26.94 27.71 29.42 30.5 31.45 35.88 54.42 45.45 41.14
Payable days 61.97 54.91 49.91 50.5 75.03 115.6 110.54 111.76 160.52 130.35 119.6
PER(x) 22.1 32.82 44.71 31.69 32.85 81.86 39.34 37.5 19 63.29 32.71
Price/Book(x) 3.35 3.97 6.35 5.45 4.02 6.51 3.88 1.89 2.41 3.6 1.54
Dividend Yield(%) 0.99 0.76 0.48 0.54 0.63 0.48 0.74 0.92 1.21 1.21 0.97
EV/Net Sales(x) 0.66 0.85 1.42 1.31 1.06 2.42 1.37 0.55 1.03 1.53 0.88
EV/Core EBITDA(x) 9.39 13.71 19.01 14.76 12.6 27.9 15.04 9.66 16.71 24.06 8.03
Net Sales Growth(%) 8.07 8.86 16.04 7.44 1.72 9.42 8.72 2.85 -26.28 25.88 21.01
EBIT Growth(%) -7.44 -6.26 32.33 29.62 -16.89 8 22.26 -46.78 7.22 15.38 138.2
PAT Growth(%) -9.12 -12.78 30.4 40.3 -17.32 -3.07 34.18 -49.46 198.57 -49.68 141.32
EPS Growth(%) -9.12 -12.78 30.4 40.3 -17.32 -46.72 34.18 -49.46 198.57 -49.68 141.31
Debt/Equity(x) 0.24 0.31 0.37 0.29 0.15 0.21 0.12 0.12 0.06 0.06 0.03
Current Ratio(x) 1.55 1.54 1.29 1.22 1.39 1.53 1.73 1.74 1.99 2.13 5.06
Quick Ratio(x) 1.27 1.22 1 0.95 1.03 1.21 1.38 1.32 1.62 1.74 4.66
Interest Cover(x) 9.5 7.58 8.23 11.68 10.37 7.37 12.62 6.94 14.22 8.67 12.76
Total Debt/Mcap(x) 0.07 0.08 0.06 0.05 0.04 0.03 0.03 0.06 0.03 0.02 0.02

TTK Healthcare Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56 74.56
FII 0 0 0 0 0 0 0 0 0 0
DII 4.58 4.8 4.85 4.59 4.5 5.37 5.67 5.07 4.98 2.98
Public 20.85 20.64 20.59 20.85 20.94 20.07 19.77 20.36 20.45 22.45
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 130.35 to 119.6days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 9% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

TTK Healthcare News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....